Court In Denmark Upholds Two Lipitor Patents, Prevents Launch Of Ranbaxy Generic Product Before November 2011

Main Category: Litigation / Medical Malpractice
Also Included In: Statins;  Pharma Industry / Biotech Industry
Article Date: 01 Sep 2008 - 2:00 PDT

Current ratings for:
'Court In Denmark Upholds Two Lipitor Patents, Prevents Launch Of Ranbaxy Generic Product Before November 2011'

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Pfizer Inc said that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company's favor in challenges to two of its patents covering atorvastatin, the active ingredient in Lipitor. The basic (DK 171,588) and enantiomer (EP 409,281) patents were challenged by generics manufacturer Ranbaxy.

The court ruled that the basic patent, which expires in November 2011, would be infringed by Ranbaxy's generic atorvastatin product. The court also ruled that the atovastatin enantiomer patent is valid. That patent expires in July 2010. The decision, which is subject to possible appeal, prevents Ranbaxy from launching its generic product before November 2011.

"Today's decision is an important outcome for Pfizer and other medical innovators who invest in high-risk research to develop life-saving medicines for millions of patients," said Pfizer Denmark Country Manager Karin Verland.

http://www.pfizer.com

Article adapted by Medical News Today from original press release.
Visit our litigation / medical malpractice section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Pfizer. "Court In Denmark Upholds Two Lipitor Patents, Prevents Launch Of Ranbaxy Generic Product Before November 2011." Medical News Today. MediLexicon, Intl., 1 Sep. 2008. Web.
23 May. 2012. <http://www.medicalnewstoday.com/releases/119839.php>
APA
Pfizer. (2008, September 1). "Court In Denmark Upholds Two Lipitor Patents, Prevents Launch Of Ranbaxy Generic Product Before November 2011." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/119839.php.

Please note: If no author information is provided, the source is cited instead.


Add Your Opinion On This Article

'Court In Denmark Upholds Two Lipitor Patents, Prevents Launch Of Ranbaxy Generic Product Before November 2011'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Litigation / Medical Malpractice

Most Popular Articles



Follow Our Litigation News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Litigation / Medical Malpractice Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »